Pathological complete response to long-course neoadjuvant alectinib in lung adenocarcinoma with EML4-ALK rearrangement: report of two cases and systematic review of case reports. - Shi L; Gao S; Tong L; Meng Q; Zhou S; Yu D; Dong Y; Liu Z (Frontiers in oncology, 2023)